Profil
Todd Young joined SG Cowen in October 2000 as a member of the hospital supply/medical technology research team.
Prior to joining SG Cowen, Dr. Young was a research assistant for Dr Benjamin Margolis at NYU Medical School, studying signal transduction in breast cancer cell lines, and was a research assistant for Dr. Robert Blank at The Hospital for Special Surgery studying the genetics of osteoporosis and osteogenesis imperfecta.
He received a B.A.
from Dartmouth College in 1992, attended the Columbia Post-Baccalaureate Pre-Medical Program in 1992-93, and received a degree in medicine from New York Medical College in 2000.
Dr. Young is primarily responsible for integrating with the investment community and representing the company on all relevant news, clinical developments, and operational progress.
Prior to joining Angiotech, Dr. Young was part of the medical device equity research team for three years at SG Cowen Securities in New York, focusing on the cardiovascular and orthopedic spaces.
Dr. Young received his medical degree from New York Medical College and also holds a Bachelor of Arts in Ecology and Environmental Studies from Dartmouth College.
He was promoted to Vice President, Investor Relations and Communications in January, 2005
Anciens postes connus de Todd Young
Sociétés | Poste | Fin |
---|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Public Communications Contact | - |
Formation de Todd Young
Dartmouth College | Undergraduate Degree |
New York Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |